Realta Investment Advisors Increases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Realta Investment Advisors boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 306.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 4,117 shares of the financial services provider’s stock after acquiring an additional 3,105 shares during the quarter. Realta Investment Advisors’ holdings in iShares Biotechnology ETF were worth $600,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in the stock. Ashton Thomas Private Wealth LLC increased its stake in shares of iShares Biotechnology ETF by 50.9% during the first quarter. Ashton Thomas Private Wealth LLC now owns 5,291 shares of the financial services provider’s stock worth $726,000 after purchasing an additional 1,784 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 16.9% during the first quarter. Sequoia Financial Advisors LLC now owns 2,409 shares of the financial services provider’s stock valued at $331,000 after acquiring an additional 349 shares during the last quarter. BNP Paribas purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $69,000. Fidelis Capital Partners LLC purchased a new position in shares of iShares Biotechnology ETF in the first quarter valued at approximately $441,000. Finally, Haverford Trust Co boosted its stake in shares of iShares Biotechnology ETF by 15.8% in the first quarter. Haverford Trust Co now owns 5,177 shares of the financial services provider’s stock worth $710,000 after acquiring an additional 705 shares during the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of IBB traded up $2.49 during trading hours on Friday, hitting $142.78. 1,390,664 shares of the stock were exchanged, compared to its average volume of 1,448,838. The stock’s 50-day moving average price is $145.02 and its two-hundred day moving average price is $140.37. iShares Biotechnology ETF has a 12-month low of $113.56 and a 12-month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.